by John Conrad | Apr 3, 2026 | Policy News
Statement from John Conrad, President & CEO, iBIO “In Illinois, we’ve seen what the right environment can deliver — with recent investments from AbbVie and CSL Behring reinforcing our state’s role as a leader in biomanufacturing and innovation. And candidly, we’d...
by John Conrad | Aug 8, 2025 | iBIO in the News
Of the $1.24 billion in venture investments pumped into Illinois’ life sciences sector last year, about half went to the state’s late-stage companies, Series A rounds accounted for 35% and early-stage companies collected 15% of the funding, according to a...
by John Conrad | Aug 5, 2025 | iBIO News
Report highlights nearly 100 life science companies and investment trends as Chicago prepares to welcome BIO International Convention 2030 CHICAGO, IL – August 5, 2025 – The Illinois Biotechnology Innovation Organization (iBIO) today released its inaugural Member...
by John Conrad | Oct 31, 2022 | iBIO in the News
Illinois’ bioscience industry has seen major growth in recent years as government grants and private investors have pumped money into the sector, according to a new report. But a shaky economy and venture-capital slowdown this year will likely hamstring...
by John Conrad | Oct 17, 2022 | iBIO in the News
Amid waning venture-capital activity in Illinois and across the country this year as macroeconomic conditions deter investors from cutting checks to startup companies, health care businesses appear to be attracting the most investor interest. Of the 10 largest VC...
